_Page_052.jpg)
The normal newborn
The vast majority of babies are born in good condition at full term and do not require any medical involvement. Most babies in the UK are born in hospital, where a paediatrician is usually available to attend ‘high-risk’ deliveries, where it is anticipated that resuscitation will be required. A healthy newborn infant should cry soon after birth, have pink mucous membranes, good muscle tone, a normal heart rate and regular respiration. They can be dried and placed on the mother’s chest. The cord is clamped after a minute or two. Skin-to-skin care helps establish breastfeeding. Newborn babies, especially premature babies, are covered in a waxy material called vernix. Post-term infants may have very dry, cracked skin. Babies pass a green – black stool called meconium that changes to a normal yellow – brown seedy stool after a few days. It is recommended that infants be given vitamin K at birth to prevent potentially catastrophic bleeding. Newborn infants are routinely examined within the first few days to exclude congenital abnormalities (see Chapter 10) and have blood taken from a heel prick around day 5 to screen for hypothyroidism and metabolic disorders (see Chapter 7).
Asphyxia and resuscitation
The perinatal mortality rate
(currently 7 per 1000) has halved in the UK over the last 20 years, largely due
to improvements in obstetric care. The reduction in neonatal mortality rate
(now less than 3 per 1000 live births) is due to improvements in the management
of babies with complex congenital abnormalities and to improved care of preterm
infants. Some babies still require immediate resuscitation after birth, and
personnel attending deliveries must be trained in effective and rapid
resuscitation. The need for resuscitation can often be anticipated and a
skilled professional should be in attendance. Such situations include the
following:
•
Prematurity
•
Fetal
distress
•
Thick
meconium staining of the liquor
•
Emergency
caesarean section
•
Instrumental
delivery
•
Known
congenital abnormality
•
Multiple
births.
Apgar score
The condition of the infant after
birth is described by the Apgar score (see opposite). Five parameters are
scored from 0 to 2. A total Apgar score of 7 – 10 at 1 min of age is normal. A
score of 4 – 6 is a moderately ill baby and 0 – 3 represents a severely
compromised infant who may die without urgent resuscitation. Such babies will
often require intubation and may require cardiac massage. In the most depressed
babies IV drugs such as adrenaline (epinephrine) and bicarbonate may be
necessary to reestablish cardiac output. The outcome for these infants
may be poor. Hypoxic-ischaemic encephalopathy (HIE) Some
infants in poor condition at birth may have suffered a hypoxic or ischaemic
insult during pregnancy or labour. A healthy fetus can withstand brief
physiological hypoxia, but an already compromised fetus may become exhausted
and decompensate with build-up of lactic acid. These infants may develop
irreversible organ damage, in particular to the brain. Umbilical cord blood gas
samples should be assessed. Evidence of severe asphyxia includes a cord blood
pH < 7.0, Apgar score of <5 at 10 mins, a delay in
spontaneous respiration beyond 10 mins and development of a characteristic
encephalopathy with abnormal neurological signs including convulsions. Death or
severe handicap occurs in more than 75% of the most severely asphyxiated
term infants. Therapeutic hypothermia (cooling to 33.5 ∘C) for
72 h can prevent secondary neuronal damage in moderate-to-severe
HIE. However, for normal, well babies, it is important to prevent hypothermia
by careful drying and early skin-to-skin contact after birth. Preterm babies
are at particular risk of hypothermia, and they should be delivered in a warm
room and enclosed in clean plastic wrap before stabilization under a heater
to help maintain normothermia.
Intrauterine growth retardation
A baby with a birth weight below
the 10th centile is small for gestational age (SGA). This may be familial or
may be due to intrauterine growth retardation (IUGR). The pattern of growth
retardation gives some indication of the cause. An insult in early pregnancy,
such as infection, will cause symmetrical growth retardation, where the head
and length are also affected. A later insult, usually placental insufficiency,
can cause asymmetric growth retardation with relative sparing of head growth
due to selective shunting of blood to the developing brain. Abnormalities of
blood flow in the umbilical or fetal vessels can now be detected using Doppler
ultrasound; these can be used to plan when to intervene and deliver the baby.
Causes of IUGR include the
following:
•
Multiple
pregnancy
•
Placental
insufficiency
•
Maternal
smoking
•
Congenital
infections (e.g. toxoplasmosis and rubella)
•
Genetic
syndromes (e.g. Down’s syndrome).
Babies with severe IUGR should be
screened for congenital infection—‘TORCH’ screen (Toxoplasmosis, Other
[syphilis], Rubella, Cytomegalovirus, Hepatitis and HIV). In the first few days
of life, babies with IUGR are at risk of hypoglycaemia and hypothermia due to
low glycogen stores and lack of subcutaneous fat. Symptomatic hypoglycaemia can
cause neurodevelopmental injury. If there has been poor head growth during
pregnancy, intellect may be impaired. Babies with IUGR must not be overfed
during infancy as there is evidence that excessive weight gain leads to
hypertension, ischaemic heart disease and diabetes in later life.
Vitamin K
Vitamin K deficiency or persistent
obstructive jaundice can lead to poor synthesis of vitamin K-dependent clotting
factors and subsequent bleeding. The bleeding may be minor bruising or
significant intracranial haemorrhage. This used to be known as haemorrhagic
disease of the newborn but is now referred to as vitamin K deficiency bleeding
(VKDB). Breast milk is low in vitamin K, unlike formula milk, which is
supplemented. For this reason, vitamin K should be given routinely to all
newborn infants, either as a single intramuscular injection or by mouth at
birth, 1 and 6 weeks. Babies with persistent jaundice should receive further
doses (see Chapter 51).